source
- BioNTech and Pfizer present bispecific cancer data at ASCO, FDA chief notes optimismAt the American Society of Clinical Oncology meeting, BioNTech and Pfizer highlighted early results from bispecific antibody programs aimed at lung cancer. The companies described the data as promi…
- Former FDA oncology chief says political turmoil opens chance to reshape agency amid rising Chinese competitionRick Pazdur, who led oncology reviews at the FDA, told a STAT audience at the American Society of Clinical Oncology meeting that recent political appointments have caused significant disruption at…